Holland & Knight represented Conduent Incorporated, while Willkie Farr & Gallaher served as independent legal counsel to the Special Transaction Committee in the transaction. Conduent Incorporated...
Conduent’s $132 Million Repurchase of Shares from Carl Icahn
Resideo’s $1.4 Billion Acquisition of Snap One and $500 Million PIPE Investment
Willkie Farr & Gallagher advised Resideo Technologies, Inc., while Simpson Thacher & Bartlett advised Snap One Holdings Corp., and Kirkland & Ellis advised Clayton, Dubilier &...
Xerox’s US$542 Million Repurchase of Shares From Carl C. Icahn and Affiliates
White & Case LLP advised Xerox , Willkie Farr & Gallagher represented the Special Committee of the Board of Directors of Xerox Holdings Corporation, and Latham...
Southwire’s $87.5 Million Acquisition of Resideo’s Genesis Cable Business
Willkie Farr & Gallagher represented Resideo Technologies, Inc. in the transaction. Resideo Technologies (NYSE:REIZ) (“Resideo”) announced a definitive agreement for the sale of Genesis Cable business to Southwire...
Cano Health’s Proxy Contest
Willkie recently represented Barry Sternlicht, Chairman and CEO of Starwood Capital Group, in his successful proxy contest at Cano Health, Inc. Cano Health announced the resignation...
Carrix’s Acquisition of Ceres Terminals
Willkie represented Carrix in the transaction. Carrix, a leading marine terminal operator in the U.S. and the Americas, announced on June 22 that it agreed to...
iCON Infrastructure’s Partnership with Royal Caribbean Group
Willkie Farr & Gallagher LLP and Chiomenti have advised iCON Infrastructure Partners VI on the deal. iCON Infrastructure Partners VI, L.P., a fund advised by iCON...
Diageo’s Acquisition of Balcones Distilling
Willkie represented Balcones Distilling in the transaction. Diageo acquired Balcones Distilling, a Texas craft distiller and one of the leading producers of American Single Malt Whisky in...
Royalty Pharma’s Acquisition of Theravance Respiratory Company
Skadden advised Theravance Biopharma, while Goodwin Procter advised Royalty Pharma on the deal. Willkie Farr & Gallagher advised Innoviva on the sale of its stake in...
Innoviva’s Acquisition of Entasis Therapeutics
Willkie Farr & Gallagher advised Innoviva on the transaction. Innoviva, Inc., a diversified holding company with a portfolio of royalties and a growing portfolio of innovative...
Resideo Technologies’ $593 Million Acquisition of First Alert
Willkie Farr & Gallagher advised Resideo Technologies in the transaction while Jones Day advised Newell Brands Inc. Resideo Technologies, Inc., a global provider of home comfort...
Théa’s Acquisition of Branded Ophthalmic Products from Akorn
Willkie Farr & Gallagher advised Akorn, and Weil, Gotshal & Manges advised Théa in the transaction. Akorn Operating Company LLC, a specialty pharmaceutical company, entered into...